The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983
Abstract
During 1988-1989 two highly distinct antigenic variants of influenza type B were recognized in hemagglutination-inhibition tests with postinfection ferret serum. These viruses were antigenically related to either B/Victoria/2/87, the most recent reference strain, or B/Yamagata/16/88, a variant that was isolated in Japan in May 1988. All influenza B viruses isolated in the United States during an epidemic in the winter of 1988-1989 were antigenically related to B/Victoria/2/87. However, in several countries in Asia, both B/Victoria/2/87-like viruses and B/Yamagata/16/88-like viruses were isolated. Sequence analysis of the hemagglutinin (HA) genes of several influenza B isolates from 1987 to 1988 indicated that the HA1 domains of the B/Yamagata/16/88-like viruses and B/VI/87-like viruses isolated in 1988 differed by 27 amino acids. Evolutionary relationships based on this sequence data indicated that the B/Yamagata/16/88-like viruses were more closely related to epidemic viruses from 1983 (B/USSR/100/83-like viruses) than to more recent reference strains such as B/Victoria/2/87. All other Asian strains, as well as selected isolates from the United States in 1988, were confirmed by sequence analysis as being genetically related to B/Victoria/2/87. These data provide clear evidence that two parallel evolutionary pathways of influenza type B have existed since at least 1983 and that viruses from each of the separate lineages were isolated from cases of influenza B in 1988. This finding is similar to earlier observations for type A H1N1 and H3N2 influenza viruses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The time from onset to death observed with fatal influenza B was more rapid than the duration of fatal illness described for pandemic 1918 A(H1N1), pandemic 1957 A(H2N2), pandemic 1968 A(H3N2), pandemic 2009 H1N1, and seasonal A(H3N2) viruses [3, 10-13, 4).”
From Myocardial Injury and Bacterial Pneumonia Contribute to the Pathogenesis of Fatal Influenza B Virus Infection (2012) · cites this paper as [4]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Wiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,623
THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS
Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,413
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)
Caton, A. J., Brownlee, G. G., Yewdell, J. W., & Gerhard, W. (1982) · Cell · doi:10.1016/0092-8674(82)90135-0 · Cited by 1,036
Both, G. W., Sleigh, M. J., Cox, N. J., & Kendal, A. P. (1983) · Journal of Virology · doi:10.1128/jvi.48.1.52-60.1983 · Cited by 327
Geographic distribution of wild poliovirus type 1 genotypes
Rico-Hesse, R., Pallansch, M. A., Nottay, B. K., & Kew, O. M. (1987) · Virology · doi:10.1016/0042-6822(87)90001-8 · Cited by 327
Evidence for host-cell selection of influenza virus antigenic variants
Schild, G. C., OXFORD, J. S., de Jong, J. C., & Webster, R. G. (1983) · Nature · doi:10.1038/303706a0 · Cited by 314
Evolution of Human Influenza A Viruses Over 50 Years: Rapid, Uniform Rate of Change in NS Gene
Buonagurio, D. A., Nakada, S., Parvin, J. D., Krystal, M., Palese, P., & Fitch, W. M. (1986) · Science · doi:10.1126/science.2939560 · Cited by 288
Differences in RNA patterns of influenza A viruses
Palese, P., & Schulman, J. L. (1976) · Journal of Virology · doi:10.1128/jvi.17.3.876-884.1976 · Cited by 223
Research works printed but not linked: 1
- World Health Organization, 1989, Recommended composition of influenza virus vaccine for use in the 1989–1990 season, WHO Weekly Epidemiol Rec., 8, 53
Cited by
Sorted by citations
Items 501–540 of 540
On the epidemiology, clinical presentation and transmission of respiratory viral infections
Sundell, N. (2020) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Could trivalent LAIV protect against both genetic lineages of influenza B virus?
Kiseleva, I., Stepanova, E., Krutikova, E. V., Donina, S., Rekstin, A. R., Bazhenova, E. A., Pisareva, M., Katelnikova, A. E., Kryshen, K. L., Muzhikyan, A., et al. (2019) · Vaccine Research · doi:10.29252/vacres.6.1.13
Yatsyshina, S. B., Renteeva, A. N., Владимировна, В. А., Elkina, M. A., Speranskaya, A. S., Pimkina, E. V., Mintaev, R. R., Markelov, M. L., & Vv, M. (2016) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2016-5-60-72
Universal Vaccines against Influenza Viruses: Overview of the Past, Present, and Prospective
Agung, Y., Stacey, H. D., D’Agostino, M. R., & Zhang, A. (2020) · McMaster University Medical Journal · doi:10.15173/mumj.v17i1.2347
Severe Illness Associated With Respiratory Viruses: Burden and Temporal Dynamics
Kubale, J. (2020) · Deep Blue (University of Michigan) · doi:10.7302/66
НОВЫЙ РОД ВИРУСА ГРИППА Influenza D virus (обзор)
человека, Ф. Н. Ц. П. З. С. И. Р., & Lyapunov, A. V. (2021) · Sel skokhozyaistvennaya Biologiya · doi:10.15389/agrobiology.2021.2.215rus
A NEW GENUS OF INFLUENZA VIRUS — Influenza D virus (review)
Lyapunov, A. V. (2021) · Sel skokhozyaistvennaya Biologiya · doi:10.15389/agrobiology.2021.2.215eng
Development of Inducible Anti-influenza Therapies
McMillen, C. M. (2016) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6203
New nucleotide sequence data on the EMBL File Server
(1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2521
New nucleotide sequence data on the EMBL File Server
(1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4317
(2009) · Journal of Christian Nursing · doi:10.1097/01.cnj.0000348286.73665.42
Dissecting Human and Influenza Virus Interaction with qFRET Technology
Liu, C., Dang, R., & Liao, J. (2022) · UC Riverside Undergraduate Research Journal Submit · doi:10.5070/rj516158744
Systems biology of human cells responded to influenza B virus infection
Sirivassanametha, K. (2018) · doi:10.58837/chula.the.2018.340
Humoral immune response after seasonal influenza vaccination
Prada, L. S.-D. (2023) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/62514
Molecular epidemiology and evolution of influenza a and b viruses
Tewawong, N. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1708
Volviendo a las vacunas trivalentes frente a la gripe humana
Reina, J., & Viana-Ramírez, J. (2024) · Vacunas · doi:10.1016/j.vacun.2024.06.006
Returning to trivalent vaccines against human influenza
Reina, J., & Viana-Ramírez, J. (2024) · Vacunas (English Edition) · doi:10.1016/j.vacune.2024.07.006
Saikia, P., Kemisetti, D., Rath, A. K., & Mishra, S. R. (2025) · Coronaviruses · doi:10.2174/0126667975364848250122083007
Gong, Y., Luo, Y., Zhi, X., Lu, X., Niu, M., Zhang, D., Wu, Y., & Yu, Y. (2025) · Journal of Virological Methods · doi:10.1016/j.jviromet.2025.115191
Nyarango, B. K., Owuor, D. C., Isoe, E. M., Mutunga, M. N., Cheruiyot, R., Katama, E. N., Makori, T., Lambisia, A. W., Nyiro, J. U., Githinji, G., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11442-z · Cited by 1
A Rare Case of Influenza B Viral Pneumonia in a 10-Day-Old Neonate
Ain, N. U., Ahmed, Z. A., Aman, S., Nisa, M., & Khushdil, A. (2025) · Cureus · doi:10.7759/cureus.91591
Spatial and Temporal Dynamics of Influenza
Stark, J. H. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Ichikawa, Y., Saito, R., Chon, I., Phyu, W. W., Kyaw, Y., Win, S. M. K., Japanese Influenza Collaborative Study Group, Yoshioka, S., Sun, Y., Li, J., et al. (2026) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.70234
Dutta, M., Sarmah, N., Siddique, A. I., Borah, P., Gogoi, S., Boruah, P., Jakharia, A., Gogoi, D., Patgiri, S. J., Biswas, D., et al. (2026) · Archives of Virology · doi:10.1007/s00705-026-06548-x
Abdulgader, S. A., Aziz, I. M., Abdulwahed, A., Aljowaie, R. M., Farrag, M. A., Almuqrin, A., Alkubaisi, N. A. O., & Almajhdi, F. N. (2026) · Viruses · doi:10.3390/v18030358
Replication Fitness of Human Influenza B Viruses in Swine Primary Respiratory Epithelial Cells
Jandhyala, S. S., Sreenivasan, C. C., Soni, S., Giri, K., Kaushik, R. S., Li, F., & Wang, D. (2026) · Journal of Medical Virology · doi:10.1002/jmv.70898
Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in mice
González‐Domínguez, I., Boza, M., Abdeljawad, A., Shea, W. R., Puente‐Massaguer, E., Mishra, M., Lemus, N., Lai, T. Y., Muramatsu, H., Lam, K., et al. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102921
Research on nanodelivery systems for nasal vaccine
Le, M. Q. (2018) · theses.fr (ABES) · doi:10.70675/69ebfffaz2030z411fz9091z496d5c90aa07 · Cited by 1
Molecular and antigenic characteristics of the influenza B virus in Guangzhou, 2022–2023
Liu, Y., Wu, S., Liu, Y., Chen, J., Xiao, J., Zhang, J., Huang, Q., Pan, W., Lin, D., Wang, Y., et al. (2026) · Virology Journal · doi:10.1186/s12985-026-03141-1
Lin, S., Zhang, G., Wang, Q., Niu, K., & Liu, Q. (2026) · Viruses · doi:10.3390/v18070745
A neuraminidase-targeted nanobody confers broad protection against influenza B virus
Jia, H., Lin, C., Guo, Y., Cai, W., Guan, R., 朱立宁, Yang, Q., Kong, H., Sun, B., Zhang, Z., et al. (2026) · Journal of Virology · doi:10.1128/jvi.00762-26
Volkhin, I. A., Dashian, M. A., Lukashev, A. N., Shipulin, G. A., & Deviatkin, A. A. (2026) · Viruses · doi:10.3390/v18080838
Bhavsar, D., Civljak, A., Bonnettaz, B., Arunkumar, G. A., Krammer, F., & Bajic, G. (2026) · Journal of Virology · doi:10.1128/jvi.00802-26
Neutralizing Antibodies Against Influenza B Viruses from Both Lineages
Allen, J., & Carlock, M. (2024) · ImmPort · doi:10.21430/m3v9i0ulq8
Metadata
- Authors
- Rota, P. A., Wallis, T. R., Harmon, M. W., Rota, J. S., Kendal, A. P., & Nerome, K.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institute of Health Sciences (JP)
- Corresponding author
- Rota, Paul A.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 1990-03
- Volume
- 175
- Issue
- 1
- Pages
- 59-68
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W1977461039
- Cited by
- 539
- References
- 33
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 22 · 2023: 18 · 2022: 31 · 2021: 32 · 2020: 36 · 2019: 40 · 2018: 41 · 2017: 23 · 2016: 31 · 2015: 30 · 2014: 29 · 2013: 30 · 2012: 14
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Virology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- influenza B, co-circulation, evolutionary lineages, antigenic variants, hemagglutinin gene, hemagglutination inhibition, molecular evolution
- MeSH terms
- Amino Acid Sequence, Antigens, Viral, Base Sequence, Biological Evolution, Genes, Viral, Molecular Sequence Data, Influenza B virus, Oligonucleotide Probes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
